TruScreen Group Limited (NZX: TRU) Application for Dual Listing of Shares on ASX

Monday 9th November 2020

INTENTION TO MAKE APPLICATION FOR DUAL LISTING OF TRUSCREEN’S SHARES ON THE ASX

Cervical cancer screening technology company, TruScreen Group Limited (NZX: TRU ) advises that it intends to undertake a capital raising initiative, by way of a public offer, to raise up to a maximum of NZD$2 million (“Offer”) in conjunction with the dual listing of its shares on the ASX.

An application will shortly be made to ASX, after the Product Disclosure Statement (“PDS”) in support of the Offer has been lodged on the Offer Register, for TruScreen to be admitted to the Official List of ASX as an ASX Foreign Exempt Listing and for quotation of the new shares to be offered in Australia on the ASX. If TruScreen is admitted to the official list of ASX, then those Australian based investors in the Offer will have their Shares quoted on the ASX.

Purpose of the Offer

The purpose of the Offer is to raise not less than NZ$1.0 million and not more than NZ$ 2 million of new capital through the issue of up to a maximum of 28,571,428 million new ordinary fully paid shares in TruScreen at an issue price of NZD 7 cents (AUD 6.5 cents).

Key terms of the offer

Description of securities being offered Ordinary fully paid shares

Price NZD 7 cents per Share, or AUD 6.5 cents per Share

Intended Opening Date of the Offer 26 November 2020

Intended Closing Date 18 December 2020

TruScreen will advise the market once it has received confirmation from the ASX that its application for admission to the Official List on the ASX has been approved, and the Offer is unconditional.

See the links below for more details:

Intention to Make Application for Dual Listing of Truscreen's Shares on the ASX

Source: TruScreen Group Limited

Comments from our readers

No comments yet